Rj. Grostern et al., Absence of type I estrogen receptors in choroidal melanoma: Analysis of Collaborative Ocular Melanoma Study (COMS) eyes, AM J OPHTH, 131(6), 2001, pp. 788-791
PURPOSE: To evaluate choroidal melanomas in enucleated eyes for the presenc
e of type I estrogen receptors.
METHODS: Fourteen consecutive eyes with large choroidal melanomas (defined
as >16-mm basal diameter and >8 mm thickness) from 14 patients (eight women
and six men with a mean age of 57 years; range, 25-74 years) enucleated in
accordance with the Collaborative Ocular Melanoma Study (COMS) protocol we
re investigated. Immunohistochemical techniques were employed to label the
choroidal melanomas for the presence of type I estrogen receptors. Each spe
cimen was then evaluated in a masked fashion by an experienced ophthalmic p
athologist for positive nuclear staining.
RESULTS: No tumors showed immunohistochemical evidence of a type I estrogen
receptor.
CONCLUSION: Type I estrogen receptors are not present in choroidal melanoma
. Estrogens are not likely to influence choroidal melanoma growth through t
raditional receptors. (Am J Ophthalmol 2001;131:788-791. (C) 2001 by Elsevi
er Science Inc. All rights reserved.).